Alpha Tau Medical (DRTS) Return on Capital Employed (2022 - 2026)
Alpha Tau Medical (DRTS) posted quarterly Return on Capital Employed of 47.84% for Q1 2026, down 219.0% year-on-year from 40.2% in Q1 2025, and up 7.1% on a QoQ basis from 44.67% in Q4 2025.
Alpha Tau Medical (DRTS) Return on Capital Employed (2022 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Return on Capital Employed for 5 consecutive years, with 47.84% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed fell 219.0% year-over-year to 47.84% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 47.84% (down 219.0% YoY) and the FY2025 annual result came in at 49.51%, up 860.0% from the prior year.
- Return on Capital Employed climbed to 47.84% in Q1 2026 per DRTS's latest filing, from 44.67% in the prior quarter.
- Over the last five years, Return on Capital Employed for DRTS reached as high as 50.04% in Q1 2025 and fell as low as 20.52% in Q2 2022.
- A 5-year average of 36.05% and a median of 36.21% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed surged 1382 bps — and 2026, when it sank 219 bps.
- Year by year, Return on Capital Employed stood at 27.84% in 2022, then gained by 28 bps to 35.76% in 2023, then rose by 26 bps to 45.17% in 2024, then fell by 1 bps to 44.67% in 2025, then gained by 7 bps to 47.84% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 47.84%, 44.67%, and 40.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | 47.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.84% |
| Dec 31, 2025 | 44.67% |
| Sep 30, 2025 | 40.49% |
| Jun 30, 2025 | 42.74% |
| Mar 31, 2025 | 50.04% |
| Dec 31, 2024 | 45.17% |
| Sep 30, 2024 | 41.03% |
| Jun 30, 2024 | 39.17% |
| Mar 31, 2024 | 36.21% |
| Dec 31, 2023 | 35.76% |
| Sep 30, 2023 | 32.88% |
| Jun 30, 2023 | 29.71% |
| Mar 31, 2023 | 28.37% |
| Dec 31, 2022 | 27.84% |
| Sep 30, 2022 | 23.74% |
| Jun 30, 2022 | 20.52% |
| Mar 31, 2022 | 26.69% |